[HTML][HTML] Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies

C Yao, S Wu, J Kong, Y Sun, Y Bai, R Zhu… - Cancer Biology & …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-associated death
worldwide. Angiogenesis, the process of formation of new blood vessels, is required for …

[HTML][HTML] Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

Y Chen, W Wang, MP Morgan, T Robson… - Frontiers in …, 2023 - frontiersin.org
Obesity is a global epidemic and overwhelming evidence indicates that it is a risk factor for
numerous cancers, including hepatocellular carcinoma (HCC), the third leading cause of …

[HTML][HTML] Cellular and molecular biology of cancer stem cells of hepatocellular carcinoma

KS Jeng, CF Chang, IS Sheen, CJ Jeng… - International journal of …, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death globally. The
cancer stem cells (CSCs) of HCC are responsible for tumor growth, invasion, metastasis …

[HTML][HTML] New therapeutics for HCC: does tumor immune microenvironment matter?

A Khanam, S Kottilil - International Journal of Molecular Sciences, 2022 - mdpi.com
The incidence of liver cancer is continuously rising where hepatocellular carcinoma (HCC)
remains the most common form of liver cancer accounting for approximately 80–90% of the …

[HTML][HTML] Oncogenic roles and related mechanisms of the long non-coding RNA MINCR in human cancers

C Chao, R Tang, J Zhao, D Di, Y Qian… - Frontiers in cell and …, 2023 - frontiersin.org
Long non-coding RNAs (lncRNAs) play vital roles in regulating epigenetic mechanisms and
gene expression levels, and their dysregulation is closely associated with a variety of …

[HTML][HTML] Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: challenges and opportunities

Q Xie, P Zhang, Y Wang, W Mei, C Zeng - Frontiers in Oncology, 2022 - frontiersin.org
Hepatocellular carcinoma is one of the leading causes of cancer mortality globally, and its
incidence is increasing. Immune checkpoint therapy has revolutionized the treatment of …

[HTML][HTML] Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence

W Liu, HS Yang, SY Zheng, JH Weng, HH Luo, YY Lei… - BMC genomics, 2022 - Springer
Abstract Background General transcription factor IIi (GTF2I) mutations are very common in
thymic epithelial tumors (TETs) and are related to a more favorable prognosis in TET …

[HTML][HTML] Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer

X Fu, Y Zhang, Q Luo, Y Ju, G Song - Cancer Biology & Medicine, 2023 - ncbi.nlm.nih.gov
Over the past 2 decades, cancer stem cells (CSCs) have been identified as the root cause of
cancer occurrence, progression, chemoradioresistance, recurrence, and metastasis …

Curcumin inhibits invasion and metastasis of human hepatoma cells through Bclaf1-mediated Wnt/β-catenin signalling

Z Zhao, J Su, J Zhao, J Chen, X Cui… - Food and Agricultural …, 2022 - Taylor & Francis
Curcumin, a kind of natural compound extracted from the rhizome of Zingiberaceae such as
turmeric, has many pharmacological effects such as anti-cancer effects. This study …

[HTML][HTML] The Effect of Adipocyte-Secreted Factors in Activating Focal Adhesion Kinase-Mediated Cell Signaling Pathway towards Metastasis in Breast Cancer Cells

N Mubtasim, L Gollahon - International journal of molecular sciences, 2023 - mdpi.com
Obesity-associated perturbations in the normal secretion of adipocytokines from white
adipocytes can drive the metastatic progression of cancer. However, the association …